Edition:
United States

NovaBay Pharmaceuticals Inc (NBY)

NBY on American Stock Exchange

4.45USD
20 Sep 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$4.45
Open
$4.40
Day's High
$4.50
Day's Low
$4.20
Volume
7,953
Avg. Vol
18,973
52-wk High
$5.09
52-wk Low
$2.25

Chart for

About

NovaBay Pharmaceuticals, Inc., formerly NovaCal Pharmaceuticals, Inc., is a biopharmaceutical company, which develops products for the eye care market. The Company focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. Avenova is an eye care product formulated with a... (more)

Overall

Beta: -0.74
Market Cap(Mil.): $68.13
Shares Outstanding(Mil.): 15.31
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 80.38 16.25
EPS (TTM): -- -- --
ROI: -- 2.96 14.87
ROE: -- 4.74 13.89

BRIEF-Novabay pharmaceuticals announces CFO transition

* Novabay Pharmaceuticals Inc - ‍current CFO Tom Paulson to retire at year end​ Source text for Eikon: Further company coverage:

Jul 10 2017

BRIEF-Novabay Pharmaceuticals reports Q1 loss per share $0.26

* Novabay Pharmaceuticals reports first quarter 2017 financial results

May 11 2017

BRIEF-Novabay Pharmaceuticals sees FY 2017 revenue $19 million

* Novabay Pharmaceuticals reports 2016 full year and fourth quarter financial results and provides 2017 financial guidance

Mar 23 2017

Competitors

  Price Chg
Realm Therapeutics PLC (RLM.L) 29.50 0.00
C R Bard Inc (BCR.N) $318.56 +0.27
Smith & Nephew plc (SN.L) 1,322.00 -11.00
Abbott Laboratories (ABT.N) $51.89 +0.48
GlaxoSmithKline plc (GSK.L) 1,454.00 +2.00
3M Co (MMM.N) $210.51 -3.05
Sanofi SA (SASY.PA) €82.30 +0.05
Pfizer Inc. (PFE.N) $35.99 +0.54
Novartis AG (NOVN.S) CHF82.90 +0.15
Johnson & Johnson (JNJ.N) $133.22 -2.00

Earnings vs. Estimates